beta-carotene soft capsules
comments( 0 )drugsinfo
ingredients: beta-carotene.
character: this product is soft capsule, brown oily suspension inside.
indication: erythropoietic protoporphyria.
specification: each capsule contains beta-carotene 15mg
directions: oral administration after meal, 4 capsules (60mg) each, 3 times daily. dosage between 30 and 200mg (2-13 capsules), one treatment about 8 weeks. for children taken, 30-150mg (2-10 capsule) each dose, 2-3 times daily. or consult a healthcare professional.
attentions:
1. during administration, individual patients may appear different degree of skin yellowing, loose stool, petechia and joint pain. all these symptoms can disappear after stopping the drug.
2. allergy to this product are prohibited.
3. persons who have severe liver and kidney damage should be careful to take this product.
4. curative effect mostly appears in two to six weeks after taking the drug, if 6 weeks did not see curative effect, dosage can be appropriately increased, until palm skin become yellowing, and then gradually reduced.
5. persons who are pregnant or nursing should consult a healthcare professional before using this.
6. during taking this product, it should not take vitamin a.
pharmacology and toxicology:
vitamin supplement. this product is a precursor of vitamin a, it has elimination process to peroxide which is produced by protoporphyrin after exposure to sunlight. in human body, through oxidase, beta-carotene free two molecules of vitamin a, and play the role of vitamin a.
pharmacokinetics:
after oral administration, by fat in the diet as the carrier, beta-carotene is absorbed by bile in the small intestine, most of prototype is stored in various tissues, especially stored in fat. a small part of beta-carotene is transferred by oxidase in liver into vitamin a, mainly by intestinal metabolism with faeces.
storage: be kept in airtight containers, in a cool and dry place (not more than 20℃) and away from sun.
packaging: high density polyethylene plastic bottles, 60caps/bottle. aluminum plastic blister packaging, 10caps×5plates/box; 9caps×1plate/box; 9caps×2plates/box.
expiration date: 24 months
productioninfo
product executive standard: ws1-(x-035)-2006z
registration number: national drug approval number h10950303
manufacturer: the central pharmaceutical co., ltd
address: no.1 fujin road, beichen district, tianjin, 300400
comment
please